AJCC 8^th edition-A step forward

Sunil S Badve^{1

2}, Carla Fisher^{1

2}

Affiliations

¹ Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
² Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Editorial

Sunil S Badve et al. Breast J. 2020 Jul.

. 2020 Jul;26(7):1263-1264.

doi: 10.1111/tbj.13907. Epub 2020 Jun 18.

Sunil S Badve^{1

2}, Carla Fisher^{1

2}

¹ Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
² Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana, USA.

No abstract available

References

1. Hortobagyi G, Connolly J, D’Orsi C, et al. AJCC cancer staging manual. Breast. 2017;589-636.
1. Kantor O, Bao J, Jaskowiak N, Yao K, Tseng J. The prognostic value of the AJCC 8th edition staging system for patients undergoing neoadjuvant chemotherapy for breast cancer. Ann Surg Oncol. 2020;27(2):352-358.
1. Yi M, Lin H, Bedrosian I, et al. Staging for breast cancer patients receiving neoadjuvant chemotherapy: utility of incorporating biologic factors. Ann Surg Oncol. 2020;27(2):359-366.
1. Kim I, Choi HJ, Ryu JM, et al. Prognostic validation of the American Joint Committee on Cancer 8th Staging System in 24,014 Korean Patients with Breast Cancer. J Breast Cancer. 2018;21(2):173-181.
1. He J, Tsang JY, Xu X, et al. prognostic staging provides no better discriminatory ability in prognosis than anatomical staging in triple negative breast cancer. BMC Cancer. 2020;20(1):18.